# Comparison of Total Mesopancreatic Excision and Conventional Pancreaticoduodenectomy in the Surgical Treatment of Pancreatic Head Adenocarcinoma: Early Postoperative Outcomes

**Authors:** Tufan Egeli, Tarkan Unek, Mucahit Ozbilgin, Cihan Agalar, Anıl Aysal Agalar, Ilkay Tugba Unek, Caner Bektas, Gokce Kıran Kazancı, Berkay Sakaoglu, Emre Karadeniz, Ozgul Sagol

PMC · DOI: 10.3390/medicina61101725 · Medicina · 2025-09-23

## TL;DR

This study compares two surgical techniques for pancreatic cancer and finds that one may offer better cancer removal without significantly more complications.

## Contribution

The study provides early evidence on the oncological and surgical outcomes of total mesopancreatic excision compared to conventional methods.

## Key findings

- TMpE-PD showed higher R0 resection rates and lymph node yield, though not statistically significant.
- TMpE-PD had more postoperative complications, but the surgical technique was not an independent risk factor.
- Smaller pancreatic duct diameter was linked to increased complication risk in both groups.

## Abstract

Background and Objectives: This study aimed to evaluate and compare the early postoperative outcomes of patients who underwent pancreaticoduodenectomy (PD) with total mesopancreatic excision (TMpE) versus conventional pancreaticoduodenectomy (Co-PD) for pancreatic head ductal adenocarcinoma (PDAC). Materials and Methods: Patients who underwent PD for pancreatic head cancer between January 2021 and December 2024 in our clinic and had a pathological diagnosis of PDAC were included. Patients were stratified into two groups according to the surgical technique performed (TMpE-PD vs. Co-PD). Demographic characteristics and early postoperative clinicopathological data were compared between the groups. Results: A total of 41 patients were included: 17 (41.5%) underwent TMpE-PD and 24 (58.5%) underwent Co-PD. Demographic and clinicopathological parameters were comparable between the groups. Although not statistically significant, the TMpE-PD group demonstrated higher R0 resection rates (58.8% vs. 45.8%; p = 0.412) and greater lymph node yield (33.9 vs. 29.1; p = 0.757) compared to the Co-PD group. Overall postoperative complications were more frequent in the TMpE-PD group (82.4% vs. 63.4%; p = 0.034). A smaller pancreatic duct diameter was associated with an increased risk of postoperative complications in both groups, approaching statistical significance (p = 0.053). Multivariable logistic regression analysis revealed that the surgical technique was not an independent risk factor for postoperative complications (OR: 0.64; 95% CI: 0.14–2.83; p = 0.56). No direct correlation was found between resection margin status (R0 vs. R1) and the development of postoperative complications. Conclusions: TMpE demonstrated non-significant trends toward higher R0 resection rates and greater lymph node yield compared with conventional PD. These findings suggest possible oncological benefits without significantly increasing perioperative morbidity.

## Linked entities

- **Diseases:** pancreatic cancer (MONDO:0005192)

## Full-text entities

- **Diseases:** PDAC (MESH:D021441), Pancreatic Head Adenocarcinoma (MESH:D006258)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12566330/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12566330/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12566330/full.md

---
Source: https://tomesphere.com/paper/PMC12566330